Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies (Q80557811)
Jump to navigation
Jump to search
scientific article published on 01 July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies |
scientific article published on 01 July 2007 |
Statements
Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies (English)
Bret Wacker
Tina Nagrani
Jacqueline Weinberg
Karsten Witt
Gary Clark